Court to allow girls to buy morning-after for now (Update)

by Larry Neumeister
This frame grab from video shows a box of Plan B morning after pill. The brief order issued by the 2nd U.S. Circuit Court of Appeals in Manhattan Wednesday June 5, 2013 permitted two-pill versions of emergency contraception to immediately be sold without restrictions, but the court refused to allow unrestricted sales of the Plan B One-Step until it decides the merits of the government's appeal. (AP Photo)

A federal appeals court is permitting girls of any age to buy generic versions of emergency contraception without prescriptions while the federal government appeals a judge's ruling allowing the sales.

The brief order issued by the 2nd U.S. Circuit Court of Appeals in Manhattan on Wednesday permits two-pill versions of emergency contraception to immediately be sold without restrictions. The court refused to allow unrestricted sales of the Plan B One-Step contraception until it decides the merits of the government's appeal.

The order has been met with praise from advocates for girls' and women's rights and scorn from social conservatives and other opponents, who argue the drug's availability takes away the rights of parents of girls who could get it without their permission.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Feds fight morning-after pill age ruling in NY

May 25, 2013

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Judge in NYC rips opposition to Plan B order

May 07, 2013

A federal judge, asked by the U.S. government on Tuesday to freeze his plan giving teenage girls broader access to morning-after birth control, instead seized the chance to accuse health officials of taking steps that would ...

Recommended for you

Supercomputers link proteins to drug side effects

2 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

9 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments